Nevertheless, the role of YTHDF1-medaited m6A modification in the hypoxia-driven emergence, development, and metastasis of breast cancer cells remains largely unknown, which hampers the potential therapeutic exploitation of the associated mechanisms. This evidence concerns the gene YTHDF1 and breast carcinoma.